Serial intravascular ultrasound evaluation of the DESolve™ novolimus-eluting bioresorbable coronary scaffold system.

Gentil BarreiraJose Ribamar CostaRicardo CostaRodolfo StaicoDaniel ChamieJuliano R SlhessarenkoLuiz Fernando TanajuraAndrea AbizaidAmanda SousaAlexandre Abizaid

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)

IVUS serial evaluation of the novel DESolve BRS showed an increase in the device dimensions between baseline and 6 months, with concomitant enlargement of lumen dimensions and effective suppression of neointimal proliferation. At 18 months, no footprint of the scaffold was detected and the initial lumen enlargement was sustained.

Keyphrases

ultrasound guided
coronary artery
tissue engineering
magnetic resonance imaging
signaling pathway
vascular smooth muscle cells
smooth muscle
aortic stenosis
angiotensin ii
left ventricular
aortic valve
transcatheter aortic valve replacement
ejection fraction